To date, the agency has authorized 23 new e-cigarette products.Read More
Despite similar state bans, the industry still has flavored products on the market. Read More
Matthew Farrelly is former chief scientist and director of RTI's Center for Health Analytics.Read More
22nd Century partnered with Cannabinoid API Solutions and Transo-Pharm. Read More
The resource center will be continuously updated, according to the FDA.Read More
The most recent U.S. regulatory plan includes “notable changes” from the previous version.Read More
The application now moves on to a preliminary scientific review. Read More
The investigation began after a leading CTP toxicologist disclosed a 2019 memo. Read More
The report found that constant leadership changes created inconsistencies in CTP policies.Read More
FDA Urged to Expand Menthol Ban
Researchers cite a study on the addiction potential of menthol cigarette alternatives.Read More
Recent Posts
- BAT Urged to List in New York
- Court Rejects Challenge to California’s Flavor Ban
- Charlotte’s Web Appoints BAT Group Head to Board
- MLB Players Switching to Zyn
- Congress Seeks to Close E-Cigarette Ad Loophole
- FDA: 99 Percent of Applications Decided
- Hearing on FDA Manufacturing Rules
- Distributor to Contest Cease-Operations Order
- Water-Based Vaping Gains Traction
- Sweden Approaching ‘Smoke-Free’ Status
- Tobacco Use Down in Cambodia
- Republic Dials Down Damages Push in Fake Papers Case
- Black Activists Split on Menthol Ban
- Call for Action Against Noncompliant Vapes
- ‘Tax Hike Will Kill Jobs and Boost Smuggling’